Compare Labiana Health SA with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.24%
- Poor long term growth as Operating profit has grown by an annual rate 0.00% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With ROE of 19.04%, it has a Very Expensive valuation with a 10.49 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.86%
0%
5.86%
6 Months
21.51%
0%
21.51%
1 Year
70.11%
0%
70.11%
2 Years
218.27%
0%
218.27%
3 Years
56.11%
0%
56.11%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Labiana Health SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
0.26
Debt to EBITDA (avg)
7.22
Net Debt to Equity (avg)
8.20
Sales to Capital Employed (avg)
1.43
Tax Ratio
23.65%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.24%
ROE (avg)
3.03%
Valuation key factors
Factor
Value
P/E Ratio
47
Industry P/E
Price to Book Value
10.49
EV to EBIT
12.48
EV to EBITDA
7.70
EV to Capital Employed
2.16
EV to Sales
1.12
PEG Ratio
0.93
Dividend Yield
NA
ROCE (Latest)
17.35%
ROE (Latest)
19.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
66.30
58.50
13.33%
Operating Profit (PBDIT) excl Other Income
9.50
3.40
179.41%
Interest
4.90
3.40
44.12%
Exceptional Items
-0.00
0.00
Consolidate Net Profit
0.20
-4.50
104.44%
Operating Profit Margin (Excl OI)
79.10%
-29.20%
10.83%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 13.33% vs 1.21% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 104.44% vs 50.55% in Dec 2023
About Labiana Health SA 
Labiana Health SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






